Actively Recruiting
Molecular Autopsy Study
Led by Scripps Translational Science Institute · Updated on 2025-01-16
100
Participants Needed
1
Research Sites
834 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study seeks to incorporate genetic testing into the postmortem examination of cases of sudden unexplained death.
CONDITIONS
Official Title
Molecular Autopsy Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Index case age between birth and 45 years
- Clinical presentation of sudden or unexplained death believed to be cardiac in nature or secondary to a massive unprovoked pulmonary embolism with no prior diagnosis of prothrombotic disease
You will not qualify if you...
- Premature death secondary to murder, suicide, or external causal event
- Premature death thought secondary to known chronic comorbid medical condition
- Premature death thought secondary to end-organ failure (kidney, liver, lung) other than heart
- Previously diagnosed with hypertrophic cardiomyopathy (HCM)
- Prior myocardial infarction regardless of stenting or bypass
- Prior cerebrovascular accident (stroke or transient ischemic attack)
- History of open heart surgery for any reason
- History of severe, untreated hypertensive heart disease
- History of illicit drug use
- History of heavy alcohol abuse
- History of severe pulmonary disease
- History of morbid obesity
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Scripps Translational Science Institute
La Jolla, California, United States, 92037
Actively Recruiting
Research Team
S
Sarah Topol, RN
CONTACT
E
Emily Spencer, Phd
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here